Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-03-18 | Vicki L. Sato, Ph.D. 2014 67 Dr. Sato serves as Professor of Management Practice of Harvard Business School where she joined the faculty in 2006. Prior to that, she had been the President of Vertex Pharmaceuticals from 2000 until her retirement from that position in 2005, and had previously served eight years as Vertex’s Chief Scientific Officer and Chair of the scientific advisory board. Prior to joining Vertex in 1992, she was with Biogen, Inc. from 1984 to 1992, most recently as Vice President of Research and a member of the scientific advisory board. Dr. Sato is also a business advisor to enterprises in the biotechnology and pharmaceutical industries. Dr. Sato serves as an overseer of the Isabella Stewart Gardner Museum. She is currently a director of Bristol-Myers Squibb Company, and PerkinElmer, Inc., and she has served as a director of Alnylam Pharmaceuticals, Inc. and Galapagos NV during the past five years. She is the author of numerous professional publications and holds several issued or pending patents. Dr. Sato received her Bachelor, Master and Doctoral degrees from Harvard University. Dr. Sato is an accomplished executive and scientist with an extensive background advising and leading research teams in life sciences innovation. Dr. Sato’s previous roles as chief scientific officer and vice president of research for multi-national companies allow her to offer guidance as we develop our technology initiatives and collaborative efforts. The expertise Dr. Sato has gained through her service on the boards of other public companies contributes broad understanding of corporate governance matters. Board Committees The current members of the Compensation Committee are Directors Drummond (Chairman), Carlson, Sato and Stallkamp. The Corporate Governance Committee. The present members of the Corporate Governance Committee are Directors Schaum (Chairman), Carlson, Drummond and Sato. Director Compensation Vicki L. Sato 99,500 fees earned or paid in cash 115,003 stock awards Total 214,503 |
| 2017-03-17 | Age: 68Director Since: 2014Other Current Directorships: Bristol-Myers Squibb Company, PerkinElmer, Inc., Syros Pharmaceuticals, Inc.BorgWarner Committees: CompensationChair, Governance |
| 2018-03-16 | Vicki L. Sato, Ph.D. Retired Professor of Management Practice, Harvard Business School Age: 69Director Since: 2014 BorgWarner Committees: Compensation Chair, Governance Director Compensation: Fees Earned or Paid in Cash: 116,000 Stock Awards: 123,005 Total: 239,005 |
| 2019-03-15 | Vicki L. Sato, Ph.D., 70 Retired Professor of Management Practice, Harvard Business School DIRECTOR SINCE 2014 OTHER CURRENT DIRECTORSHIPS Bristol-Myers Squibb Company, Syros Pharmaceuticals, Inc., Denali Therapeutics, Inc. BORGWARNER COMMITTEES Compensation Chair, Governance Director Compensation Table: Vicki L. Sato 121,500 Fees Earned or Paid in Cash, 130,000 Stock Awards, Total 251,500 |
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-30 | Vicki L. Sato, PH.D. Lead Independent Director Age: 70 Director Since: 2006 Board Committees: Committee on Directors and Corporate Governance (Chair); Science & Technology Committee 2018 total compensation $388,312 |
| 2020-03-25 | Vicki L. Sato, Ph.D. Lead Independent Director Director Since: 2006 Age: 71 Board Committees • Committee on Directors and Corporate Governance (Chair) • Science & Technology Committee ...Vicki L. Sato, Ph.D. received $393,241 total compensation in 2019. |
Data sourced from SEC filings. Last updated: 2026-02-03